Clinical Trial Update: A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors. [NA]

View source ↗

Summary

A clinical trial evaluating the combination of hV01 oncolytic vaccinia virus and a PD-1 inhibitor in advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PD-1 inhibitor
• hV01 oncolytic vaccinia virus (oncolytic vaccinia virus (hV01))

Snippet

Sponsor: Hangzhou Converd Co., Ltd. | Conditions: Advanced Solid Tumors | NA | Status: RECRUITING